At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke
In Brief
A Phase 2 clinical trial evaluating Telerehabilitation, Sinemet Pill, and 1 other intervention for Stroke. Completed, enrolled 25 participants across 1 site.
Detailed Summary
This study explores the effects of telerehabilitation and a study medication on rehabilitation outcomes in patients with stroke resulting in arm weakness. Patients with arm weakness due to a stroke that happened in the past 30 days will be randomized into one of three groups: \[1\] TR and placebo (a sugar pill) on top of usual care; \[2\] TR and a medication (Sinemet 25/100) on top of usual care; \[3\] or usual care alone (no TR and no pill, but people in this group will be offered TR once the study is done). TR consists of 70 minutes/day of activities targeting arm function, 6 days a week for 6 weeks.
Study Details
Timeline
Interventions
The telerehabilitation system will deliver rehabilitation treatment sessions via a secured internet-connected computer. TR sessions will be a combination of games, exercises, stroke education, assessments, in addition to videoconferencing with therapists to discuss progress, issues, goals, and changes to the treatment plan.
Sinemet 25/100 will be taken 1 hour prior to TR, for the first 18 sessions.
Placebo will be taken 1 hour prior to TR, for the first 18 sessions.